Systemic tumour necrosis factor (TNF) is present in jaundiced mice. Two soluble TNF receptors, sTNFr-P55 and sTNFr-P75 are reported to play a part in the natural defence against TNF. This study investigated the properties ofcirculating TNF and sTNFr in jaundiced mice. The data show that TNF in these mice is biologically inactive and that an increase of both sTNFr is seen (p<0.001). Surgical trauma in jaundiced mice is known to be accompanied by a high mortality (36%) and increased TNF concentrations. This study shows that both systemic TNF and sTNFr concentrations are increased after surgical trauma in jaundiced mice and that sTNFr concentrations rather than TNF concentrations were found to be correlated with mortality. In line with this finding this study showed that lactulose pretreatment before a surgical trauma in these mice significantly reduces postoperative concentrations of sTNFr-P75 (p<0005) and mortality (0%; p<005) without reducing TNF concentrations, while anti-TNF antibodies were ineffective. In conclusion, these data suggest that TNF in biliary obstruction is rapidly inactivated by increased concentrations of sTNFr. Furthermore, sTNFr concentrations rather than TNF concentrations show a good correlation with mortality after surgery in obstructive jaundice. The positive effect oflactulose on mortality could be caused by a decreased inflammatory status.
Increased concentrations of tumour necrosis factor (TNF) and soluble TNF receptors in biliary obstruction in mice; soluble TNF receptors as prognostic factors for mortality M H A Bemelmans, J W M Greve, D J Gouma, W A Buurman Abstract Systemic tumour necrosis factor (TNF) is present in jaundiced mice. Two soluble TNF receptors, sTNFr-P55 and sTNFr-P75 are reported to play a part in the natural defence against TNF. This study investigated the properties ofcirculating TNF and sTNFr in jaundiced mice. The data show that TNF in these mice is biologically inactive and that an increase of both sTNFr is seen (p<0.001). Surgical trauma in jaundiced mice is known to be accompanied by a high mortality (36%) and increased TNF concentrations. This study shows that both systemic TNF and sTNFr concentrations are increased after surgical trauma in jaundiced mice and that sTNFr concentrations rather than TNF concentrations were found to be correlated with mortality. In line with this finding this study showed that lactulose pretreatment before a surgical trauma in these mice significantly reduces postoperative concentrations of sTNFr-P75 (p<0005) and mortality (0%; p<005) without reducing TNF concentrations, while anti-TNF antibodies were ineffective. In conclusion, these data suggest that TNF in biliary obstruction is rapidly inactivated by increased concentrations of sTNFr. Furthermore, sTNFr concentrations rather than TNF concentrations show a good correlation with mortality after surgery in obstructive jaundice. The positive effect oflactulose on mortality could be caused by a decreased inflammatory status. (Gut 1996, 38: 447-453) Endotoxaemia is reported to be present in biliary obstruction in humans as well as in animals.' 2 Moreover, tumour necrosis factor (TNF al, unless stated otherwise), an indicator of an ongoing inflammatory process, is present in the circulation of biliary obstructed mice.3 It was shown that surgery in biliary obstructed mice resulted in an increase in circulating TNF and in a high mortality.4 Various anti-TNF treatments such as an anti-TNF mAb and lactulose, an agent that reduces TNF release by macrophages in vitro,5 have been tested. Lactulose syrup given orally before operation was the only agent that reduced the mortality after surgery in these mice by a still unresolved mechanism, this in contrast with preoperative anti-TNF treatment. These data suggested that blocking circulating TNF, using anti-TNF mAb, is not crucial in preventing the observed mortality.4 This is in contrast with the effect of anti-TNF mAbs in septic models where anti-TNF treatment was shown to be highly effective. To investigate the inflammatory response in obstructive jaundice, we studied the role of TNF and sTNFr in obstructive jaundice. Moreover, as surgery in obstructive jaundice was associated with a high mortality and lactulose was shown to reduce lipopolysaccharide induced TNF release in vitro and to reduce endotoxaemia and survival in vivo,1 4 Renal ischaemia -mice underwent a BDL or sham operation. BDL mice were randomised into four experimental groups: group 1, BDL mice receiving from day 11-14 twice daily 03 ml distilled water orally (by gavage) followed by renal ischaemia at day 14 (BDL-renal ischaemia); group 2, BDL mice receiving from day 11-14 twice daily 0.2 ml 30% lactulose syrup orally followed by renal ischaemia at day 14 (BDL-Syr); group 3, BDL mice receiving from day 11-14 twice daily 0.2 ml crystalline lactulose (200 mg/ml) orally followed by renal ischaemia at day 14 (BDL-Crys); group 4, BDL mice receiving 0.5 mg of the monoclonal anti-TNF antibody (TN3) intraperitoneally dissolved in 0.5 ml saline seven hours before the operation (BDL-TN3). The antibody was given seven hours before renal ischaemia because previous data in acute septic models showed a high efficacy when given at that time point.2' A control group of seven mice receiving 0.5 ml saline intraperitoneally seven hours before the operation was used as a control group for group 4. However, because the results after renal ischaemia were not different from control group 1, which received fluid orally, these data are not shown.
The two different lactulose preparations were used as in vitro experiments showed that lactulose syrup is a more powerful TNF inhibitor than crystalline lactulose.5 Moreover, these data show that lactulose itself is not functional. Preliminary data show that the difference is possibly caused by differences in purification processes. The presence of 3-DGP, which is reported to be a biological anti-inflammatory agent, which is absent in crystalline lactulose could play a part in this phenomenon. 23 Unfortunately, sufficient amounts of 3-DGP, necessary to further unravel this difference are lacking at this moment. Blood for TNF and sTNFr measurements was collected 90 minutes and 24 hours after renal ischaemia after which the mice were exsanguinated. During these 24 hours mortality was monitored. Animals with leakage of bile or animals that did not survive the first 90 minutes after reperfusion were excluded from the experiment. After correction for mortality during renal ischaemia, the remaining animals were divided as follows over the groups: group 1: n=14, group 2: n=1, group 3: n= 11, group 4: n= 11; sham operated group 5: n=9 (Table I) .
ELISA for murine TNF ELISA for murine TNF was performed as described earlier by Dentener.24 The ELISA has a lower detection limit of 50 pg/ml TNF. The ELISA recognises free TNF as well as TNF bound to binding proteins (immunologically detectable TNF).
WEHI 164 cytotoxicity bioassay Biological TNF activity was measured using the murine fibrosarcoma WEHI 164 cell line.25 26 The MTT method was used to assess cell killing as described previously.27 LD50 ranged between 10 and 40 pg/ml.
ELISA for soluble murine TNFr ELISA for murine sTNFr was performed as described earlier. '7 The detection limit for murine sTNFr-P55 is 5 pg/ml and for murine sTNFr-P75 50 pg/ml. 18 hours after implantation compared with control mice (Table II) . The data show that the renal blood flow in BDL mice is only transiently reduced and the results suggest that this reduction is most probably caused by surgery. After surgery, the renal blood flow gradually improves resulting in comparable renal blood flow after 52 hours between BDL and control mice. The results of the urea concentrations and the renal blood flow data in BDL mice suggest that renal function is not or negligibly affected in BDL mice.
Circulating TNF and kinetics of sTNFr after BDL Circulating TNF concentrations measured by ELISA before operation were below detection limit. After sham BDL operation, TNF concentrations remained undetectable during the experimental procedure. In the BDL group, however, there was a clear increase in circulating TNF that became evident after eight days, reaching peak concentrations after 16 days of 1.6 ng/ml (p<0.001; data not shown). Biologically active TNF could not be detected by the WEHI-bioassay in any of the samples, suggesting that TNF circulates as biologically inactive TNF-sTNFr complexes.
Whereas TNF is not detectable in serum of normal non-treated mice, we detected approximately 90 pg/ml sTNFr-P55 and 5.5 ng/ml sTNFr-P75 in normal control mice, 500 -A rapid increase in both sTNFr-P55 concentrations and sTNFr-P75 concentrations. 400 sTNFr-P55 concentrations showed peak con---~-------| centrations of 400 pg/ml after 12-16 days (p<0 01 compared with sham operated con-300 -trols; Fig IA) , while sTNFr-P75 concentrations showed peak concentrations after 12 days of 34 ng/ml (p<0 01 compared with the 200 ,,' sham operated controls ; Fig 1 B (Fig 2) . Serum samples previously. 17 Sham BDL taken 90 minutes after renal ischaemia showed d in a negligible increase that serum TNF concentrations were significoncentrations, whereas cantly increased in group 1 (BDL-renal entrations remained similar. ischaemia group). As expected, TNF concen-)n, however, resulted in a trations were significantly reduced in group 4 (anti-TNF group) compared with group 1, while they were not statistically different in group 2 (lactulose syrup group) and 3 (crystalline lactulose group) compared with group 1 (Fig 2) . Moreover, no significant differences were seen between serum TNF concentrations of BDL mice before renal ischaemia from groups 1-4 that subsequently died compared with TNF concentrations of survivors (p=0-91), nor was this difference present 90 minutes after renal ischaemia (p=0.54). In none of the animals was the TNF as detected by ELISA biologically active after renal ischaemia (data not shown).
In the four individual treatment groups (groups [1] [2] [3] [4] , sTNFr-P55 concentrations and sTNFr-P75 concentrations were similarly increased preoperatively before renal ischaemia (Fig 3 A and B) , while sTNFr concentrations in the sham group (group 5) were at the same level as normal control mice. After renal ischaemia, a significant increase was seen ( Fig 3 A and B Mortality Mortality in the BDL-renal ischaemia group was 36% (Table III) . Pretreatment with TN3 or crystalline lactulose did not reduce mortality (both 45%). However, in agreement with previous published data, lactulose syrup significantly reduced mortality (0%; p<0 05). Preoperatively, there was a significant difference between both sTNFr-P55 and sTNFr-P75 concentrations in mice of group 1-4 that survived renal ischaemia compared with the mice of those groups that did not survive renal ischaemia (p=0.035 and p<0 005, respectively). This difference was also present 90 minutes after renal ischaemia (p<0 001 and p<0 001, respectively; Fig 4) .
Discussion
The presence of the cytokine TNF in the circulation is considered to be indicative of the presence of an ongoing inflammatory response.37 Increased concentrations of circulating sTNFr, which are considered to be antagonists of TNF, are also seen in the circulation during inflammation.'9 20 During experimental endotoxaemia, sTNFr concentrations are strongly increased and remain, in contrast with systemic TNF, increased for a longer period of time.'6 17 20 The concentrations of sTNFr therefore can be considered, at least in part, as a consequence of TNF release. In previous studies,11 38 we obtained substantial evidence that the half life of these complexes is indeed longer than the half life of TNF alone and that the renal function is important in the clearance of these complexes. Therefore, sTNFr concentrations seem to be of value for monitoring the inflammatory response.
As obstructive jaundice is associated with endotoxaemia, we also determined sTNFr as well as TNF in BDL mice. The data showed that in BDL mice both TNF and sTNFr concentrations (sTNFr-P55 as well as sTNFr-P75) are considerably increased, indicating an ongoing inflammatory process. These findings support previous data from our group showing the presence of systemic TNF and interessed leukin 6, indicative for an inflammatory process in BDL mice.3
The presence of the detected TNF (bioactive and immunoreactive TNF) in BDL nces mice probably points to the presence of an the ongoing synthesis of TNF after which the prothe tein is rapidly inactivated in the circulation.'0 cease We hypothesise that this inactivation is, at least renal partially, caused by formation of bio-inactive, oup, immunologically detectable complexes of iffer-TNF with sTNFr. Indeed, we observed ntra-increased concentrations of both sTNFr in ilose ,DL- the circulation of BDL mice. Nevertheless, while TNF concentrations increased during the progression of obstructive jaundice, sTNFr concentrations reached plateau concentrations and sTNFr-P75 decreased after several days. Because Intervention with lactulose syrup was the only treatment that resulted in a significantly reduced mortality while systemic TNF concentrations were not significantly reduced. This is in agreement with previous data that showed that TNF was of little prognostic importance for mortality. 4 44 In contrast, sTNFr concentrations were found to be strongly correlated with mortality after surgery in jaundiced mice. The fact that the mice die despite high sTNFr concentrations, which are considered protective, could be because the amount of sTNFr is not sufficient to block all TNF effects, especially the effects in local tissue. Moreover, according to Aderka et al, these TNF-sTNFr complexes are potentially hazardous because they could function as slow release reservoirs.18
The protective mechanism of lactulose syrup is thus far unclear. The significant reduction in sTNFr-P75 concentrations suggest that the effect of lactulose syrup on mortality is the result of reduction of the inflammatory status of the mice. Lactulose syrup could reduce the inflammatory status by its reported reduction of endotoxaemia by inactivating endotoxins originating from the gut.' However, a direct effect of lactulose on cytokine production by mononuclear phagocytes could also be responsible.5 The fact that crystalline lactulose is not as effective as lactulose syrup is in agreement with previous data showing that lactulose syrup is a more potent lipopolysaccharide inactivator1 and reduced more effectively TNF production of mononuclear phagocytes after lipopolysaccharide stimulation. 5 The difference in effect between lactulose syrup and crystalline lactulose is expected to result from differences in purification process of both lactulose preparations. The putative presence of 3-deoxy-D-glyceropentulose (a compound that is known for its antiproliferative and cytotoxic properties) could play a part in the observed differences. 23 In pilot experiments with different lactulose contaminants, 3-DGP seemed to inhibit TNF release after injection of endotoxin in mice (data not shown).
As already mentioned, increased concentrations of sTNFr are not only a result of an inflammatory response but are also influenced by renal function. 36 45 Recently, we found that plasma concentrations of both sTNFr are affected to an identical extent by decreased renal function (data not shown). After renal ischaemia, lactulose syrup affected only sTNFr-P75 concentrations, but not sTNFr-P55 concentrations. Because of the discrepancy between both sTNFr concentrations, it is concluded that the reduction of sTNFr-P75 concentrations after renal ischaemia was more likely to be the result of the reduced inflammatory status rather than decreased clearance of the sTNFr by the kidneys. We cannot exclude, however, that the increased sTNFr concentrations after renal ischaemia are partially caused by diminished renal function.
In conclusion, the presence of TNF in inactivated form together with increased concentrations of both sTNFr in the circulation of mice with biliary obstruction is indicative for an ongoing inflammatory process. Furthermore, the data show that sTNFr concentrations, in contrast with systemic TNF concentrations, correlate with mortality after a surgical trauma in jaundiced mice. Lactulose syrup treatment is associated with a positive effect on mortality and with a reduction of sTNFr-P75 concentrations, which suggests that the inflammatory response is reduced, although the underlying mechanism remains unclear. The clinical importance of increased sTNFr concentrations as an indicator for inflammation after surgery in obstructive jaundice remains to be elucidated. 
